🎉 Our new study is now published in JCO Global Oncology! 💊🖐️ Topical Diclofenac for Prevention of Capecitabine-Induced Hand-Foot Syndrome: A Prospective Real-World Study 🔬 In this prospective, two-center real-world study of 151 patients receiving capecitabine-based therapy, we evaluated prophylactic topical diclofenac for the prevention of clinically significant hand-foot syndrome (HFS). 📊 Grade ≥2 HFS occurred in 16.9% (12/71) with topical diclofenac versus 13.8% (11/80) with active monitoring (OR 1.28; 95% CI, 0.52–3.10; P = .591). 💡 Our findings showed that prophylactic topical diclofenac did not reduce clinically significant HFS or delay its onset in routine clinical practice, adding prospective real-world evidence to this evolving area of supportive oncology. 🙏 Special thanks to our first author, Dr. Orhun Akdoğan(@drOrhunakdogan) and our mentor, Dr. Osman Sütcüoğlu(@osutcuoglu) for their leadership and guidance, and to our entire team(@uyargalip, @kbaskurtt, @yucelbirkadriye) for their valuable contributions. Grateful to be part of this collaboration! 📖 @JCOGO_ASCO | @ASCO 🔗 ascopubs.org/doi/pdf/10.1200… #JCOGlobalOncology #ASCO #Oncology #SupportiveCare #Capecitabine #HandFootSyndrome #RealWorldEvidence @KVanLoonMD @RyanNipp @thenasheffect @IshwariaMD @ASCOPres

🚨 New in International Journal of Cancer! 🎉 🧤Our NEURO-GLOVE Trial shows that a simple, low-cost dual-site compression strategy 🦵 (surgical gloves + compression stockings during paclitaxel infusion) meaningfully reduces chemotherapy-induced peripheral neuropathy (CIPN) in women with gynecologic cancers. 🔹 Grade ≥2 CIPN: 53.9% → 35.5% at Cycle 3 🔹 Benefit sustained out to 6 months 🔹 Hands protected immediately; feet protected later but durably 🔹 Cheap, scalable, ready for clinic tomorrow 🙏Huge congrats to Dr. Kadriye Başkurt (@kbaskurtt) for carrying this from idea to publication, and to our whole team[Dr.Galip Can Uyar (@uyargalip), Dr.Osman Sütcüoğlu (@osutcuoglu)] for the ride. 📖 Başkurt K, Uyar GC, Yeşilbaş E, et al. Limb Compression Therapy and Chemotherapy-Induced Peripheral Neuropathy in Women With Gynecologic Cancers: A Prospective Self-Controlled Study (NEURO-GLOVE Trial). Int J Cancer. 2026. 🔗 doi.org/10.1002/ijc.70601 #Oncology #CIPN #GynecologicCancer #Paclitaxel #SupportiveCare #NEUROGLOVE @CoquardRay @dimeglio_anto @RyanNipp @IshwariaMD @thenasheffect @realbowtiedoc

🏆🏆 Proud to share that we completed the 13th Turkish Medical Oncology Congress with two awards as a team. 👍 Our PRO-HAND study received the Best Oral Presentation Award, led by my mentor Dr. Osman Sutcuoglu ( @osutcuoglu ) 🙏 Grateful to Dr. Kadriye Başkurt (@kbaskurtt ), Dr. Tuba Uğur Tuzca ( @tubaugurdr ), and Dr. Orhun Akdoğan ( @drOrhunakdogan ) for their valuable contributions 👏 Special congratulations to Dr. Galip Can Uyar ( @uyargalip ) for the Best Paper Award 🎯 Thanks to the organizing committee, especially Dr. Deniz Can Güven ( @DenizCanGuven1 ), Dr. Şahin Laçin ( @DrSahinLacin ), and Dr. Mehmet Ali Nahit Şendur ( @nahit_sendur ), for an outstanding congress 🌍 It was a great pleasure to host distinguished experts such as Dr. Jonathan Lim ( @DrJonLim ), Dr. Benedikt Westphalen ( @BenWestphalen ) , Dr. Aung Naing ( @ANaingMD ), Prof. Andrés Cervantes ( @AndresC27622123 ), Prof. Christopher Sweeney ( @ChrisSweens1 ), Dr. Marco Tagliamento ( @M_Tagliamento ), Dr. Samer Srour , Prof. Tom Powles ( @tompowles1 ), and Prof. Syed Hussain ( @ProfSyedHussain ) 🌐 We will continue working to strengthen the global visibility of our oncology community and represent our country at the highest scientific level🇹🇷 #Oncology #MedicalOncology #CancerResearch #TTOD #GlobalOncology #ASCO #ESMO